Efficacy of SGLT2 inhibitor
Not Applicable
- Conditions
- Diabetic nephropathy
- Registration Number
- JPRN-UMIN000036183
- Lead Sponsor
- ihon University Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1. Intotelance for SGLT2 inhibitors 2. Past history of SGLT2 inhibitor before to 4 weeks at enrollment 3. Past history of administration of ESA before 12 weeks at enrollment 4. Ftn <50 ng/mL and TSAT <20% 5. HbA1c > 10.0% 6. Type 1 diabetes 7. eGFR<45mL/min/1.73m2 8. Pregnancy 9. alchol misuse 10. Severe ketosis, infection, and coma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin concentration, erythropoietin concentration
- Secondary Outcome Measures
Name Time Method albuminuria, eGFR, urinary biomarkers